[1]
“A randomized controlled trial to compare the efficacy and safety of glycopyrronium bromide + salmeterol/fluticasone and tiotropium bromide + salmeterol/fluticasone in chronic obstructive pulmonary disease”,
ijmhs, vol. 10, no. 05, pp. 853–857, May 2020, Accessed: Oct. 23, 2026. [Online]. Available:
http://www.innovativejournal.in/index.php/ijmhs/article/view/2917